Developer docs
API playgroundTry for free, no card

Search company profiles

Massachusetts Eye and Ear Infirmly

Full company profile

uuid000m8o2

Namestring
Massachusetts Eye and Ear Infirmly
Legal namestring
Massachusetts Eye and Ear
Company typeenum
Private
Founded yearint
1824
Descriptiontext

Massachusetts Eye and Ear Infirmary (Mass Eye and Ear) is a private, nonprofit academic medical center founded in 1824 and headquartered at 243 Charles Street, Boston. It is the primary teaching hospital of Harvard Medical School's Departments of Ophthalmology and Otolaryngology and a member of the Mass General Brigham health system. The institution delivers specialty clinical care exclusively across eye, ear, nose, throat, head, and neck conditions — including cornea, retina, glaucoma, neuro-ophthalmology, pediatric ophthalmology, audiology, head and neck cancer surgery, facial plastics, sinus, sleep medicine, thyroid/parathyroid, and voice/swallowing services — supported by a 24/7 dedicated emergency department that treats over 20,000 patients per year and is the only such facility in New England.

The organization operates through more than 20 physical locations across greater Boston and Providence, plus virtual visits and a dedicated International Patient Center. Underlying clinical capabilities rest on a research-to-care pipeline anchored by the Schepens Eye Research Institute (subsidiary since 2011), which together make Mass Eye and Ear the world's largest vision and hearing research center. The institution has pioneered several foundational ophthalmic technologies — Optical Coherence Tomography (OCT), anti-VEGF therapy for wet AMD (Macugen and foundational science behind Lucentis), photodynamic therapy, and proton beam therapy for eye tumors — and is currently advancing OTOF gene therapy for inherited deafness (90% response rate, 2.5+ year durability in trial) and CALEC limbal stem cell transplantation for limbal stem cell deficiency (93% manufacturing success).

Revenue is generated through clinical care billed to insurance, Medicare/Medicaid, and self-pay patients (including a self-pay laser vision correction promotion at $500 per procedure or $250 per eye), supplemented by industry- and government-funded clinical research. The go-to-market is direct-to-consumer with patients acquired via physician referrals, scheduled appointments, walk-in emergency visits, and an international patient office. Notable commercial signals include a $1M Yawkey Foundation grant for ED renovation (September 2025), training of more than 80 current chiefs at peer institutions, and ongoing international collaborations with Fudan University (China), Aravind Eye Hospital (India), and LV Prasad Eye Institute (India).

Short descriptiontext

Massachusetts Eye and Ear Infirmary is a Harvard Medical School teaching hospital and Mass General Brigham member delivering specialty clinical care and research across ophthalmology and otolaryngology, serving patients through 20+ locations in greater Boston and Providence and a 24/7 dedicated emergency department.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices22 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty hospital services, ophthalmology care, otolaryngology care, vision research, hearing research
Industry1 code
1Ophthalmic Specialty Hospitals
CodeHLAFAHAJPrimaryYes
NAICS code4 codes
  • Specialty (except Psychiatric and Substance Abuse) Hospitals62231
  • Offices of Optometrists62132
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists62134
  • Offices of Physicians62111
SIC code2 codes
  • Services-General Medical & Surgical Hospitals, Nec8062
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Specialty Hospital Services - Ophthalmology and Otolaryngology
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Patient Care Services
TypeSubscription Recurring
Description

Clinical services including emergency department (24/7), outpatient visits, diagnostic tests, and surgical procedures across ophthalmology and otolaryngology specialties. Revenue generated through insurance reimbursements, government programs (Medicare/Medicaid), and patient payments.

masseyeandear.org
2Specialty Surgical Procedures
TypeOne Time License
Description

Advanced surgical interventions including cataract surgery, LASIK, cochlear implants, head and neck cancer surgery, thyroid/parathyroid surgery. Billed per procedure with facility fees.

masseyeandear.org
3Clinical Research
TypeProfessional Services
Description

Government and industry-funded clinical trials generating research revenue while providing cutting-edge treatments to patients.

masseyeandear.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details2 tiers
1Standard specialty care consultation and treatment
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Services billed through insurance with co-pays, coinsurance, and deductibles. International patients may pay directly. Specific pricing not publicly disclosed.

masseyeandear.org
2Laser vision correction surgery promotional pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$500 total or $250/eye discount available during promotional period (June 1 to August 31, 2026). Code 'SUN' required when booking. Surgery at Lexington location within 60 days of evaluation to qualify.

masseyeandear.org
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Massachusetts Eye and Ear is a specialty academic medical center providing clinical care, research, and training in ophthalmology and otolaryngology. It operates a comprehensive portfolio of subspecialty clinical services spanning eye care (cornea, retina, glaucoma, cataract, neuro-ophthalmology, pediatric ophthalmology, refractive surgery, ophthalmic plastic surgery) and ear, nose, throat, head and neck care (audiology, head and neck cancer, facial plastics, sinus, sleep medicine, thyroid/parathyroid surgery, voice and swallowing). The institution runs New England's only 24/7 dedicated eye and ENT emergency department, conducts clinical trials including gene therapies for inherited deafness and blindness, and serves as the primary teaching hospital of Harvard Medical School's Departments of Ophthalmology and Otolaryngology.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 90% of 42 participants showed hearing improvement from OTOF gene therapy with results lasting 2.5+ years
+3 more records
Product overview1 text field

Mass Eye and Ear is a specialized academic medical center offering a comprehensive portfolio of clinical services across ophthalmology (eye care) and otolaryngology (ear, nose, throat, head and neck care), with supporting clinical and support services. The institution operates as a single integrated healthcare delivery system rather than a platform-plus-modules architecture, organized into distinct clinical subspecialties including Cornea, Retina, Glaucoma, Neuro-Ophthalmology, Audiology, Head and Neck Cancer Surgery, Facial Plastics, Sinus Center, Sleep Medicine, Thyroid/Parathyroid Surgery, and Voice/Swallowing services, among others. Supporting infrastructure includes emergency care (New England's only 24/7 dedicated ENT/eye emergency department), hyperbaric medicine, radiology, interpreter services, and a patient portal (Mass General Brigham Patient Gateway). The institution also conducts clinical trials for experimental treatments including gene therapies for inherited deafness and CRISPR-based treatments for inherited blindness.

Product and service18 records
1Optometry and Contact Lens Service
CategoryClinical service
Description

Comprehensive eye examinations, eyeglass prescriptions, and contact lens fitting services including specialty lenses for keratoconus, astigmatism, bifocal, prosthetic, and post-surgical applications. For patients requiring corrective lenses and specialty contact lens fitting.

2Retina Service
CategoryClinical subspecialty
Description

Diagnosis and treatment of retinal diseases including age-related macular degeneration (AMD), diabetic retinopathy, retinal detachment, and inherited retinal disorders using advanced tools and clinical trials. For patients with retinal conditions.

3Cornea Service
CategoryClinical subspecialty
Description

Treatment of corneal diseases including stem cell transplantation, ocular surface reconstruction, lamellar keratoplasty, artificial cornea transplants, and Corneal Tissue Addition Keratoplasty (CTAK). For patients with common, complex, and high-risk corneal and external diseases.

4Glaucoma Service
CategoryClinical subspecialty
Description

Full-spectrum glaucoma care including medical therapy, traditional surgery, and minimally invasive glaucoma surgeries (MIGS) for patients of all ages with all forms and stages of the disease.

5Neuro-Ophthalmology Service
CategoryClinical subspecialty
Description

Treatment of complex central nervous system disorders affecting vision including optic neuritis, ischemic optic neuropathy, brain tumors, strokes, myasthenia gravis, and diplopia. Sees just under 6,000 patients each year.

6Laser Vision Correction/Refractive Surgery
CategoryClinical service
Description

Laser eye surgery including LASIK, SMILE, PRK, EVO ICL implantable lenses, and refractive lens exchange for correction of nearsightedness, farsightedness, astigmatism, and presbyopia.

7Comprehensive Ophthalmology and Cataract Consultation
CategoryClinical service
Description

Routine eye exams, cataract surgery, and management of common eye problems performed by comprehensive ophthalmologists at multiple Boston-area locations.

8Pediatric Ophthalmology
CategoryClinical subspecialty
Description

Eye care for children including routine vision screenings and treatment of conditions such as retinopathy of prematurity, childhood cataract, glaucoma, strabismus, and amblyopia, in collaboration with Children's Hospital.

9Ophthalmic Plastic Surgery
CategoryClinical subspecialty
Description

Surgical treatment of functional disorders of eyelids, eye socket, and tear drainage system, plus cosmetic procedures including eyelid surgery, BOTOX, and injectable treatments.

10Ocular Immunology and Uveitis Service
CategoryClinical subspecialty
Description

Diagnosis and treatment of inflammatory eye diseases (uveitis) and immunological disorders, working across retina, cornea, immunology, and uveitis specialties.

11Audiology and Hearing Services
CategoryClinical service
Description

Hearing assessment, hearing aids, cochlear implants, bone conduction devices, auditory brainstem implants, and pediatric hearing services across 11 locations in Eastern Massachusetts.

12General Ear, Nose, and Throat Care
CategoryClinical service
Description

Initial assessment and treatment for wide variety of ENT disorders in adults and children including infections, throat/swallowing disorders, voice problems, nasal/sinus disorders, and thyroid conditions. Provided by 70+ physicians across 15 locations.

13Facial Plastic and Reconstructive Surgery
CategoryClinical service
Description

Reconstructive and cosmetic procedures including rhinoplasty, facial nerve disorders, skin cancer treatment, laser procedures, and microtia/ear reconstruction at five New England locations.

14Head and Neck Cancer Surgery
CategoryClinical service
Description

Diagnosis, treatment, reconstruction, and rehabilitation of head and neck cancers using advanced surgical techniques including microvascular surgery, robotic surgery, and skull-base surgery.

15Rasmussen Family Sinus Center
CategoryClinical center
Description

Evaluation and treatment of sinus problems including chronic sinusitis, nasal congestion, smell/taste disorders, nasal polyps, tumors, and CSF leaks using latest medical and surgical techniques.

16Sleep Medicine and Surgery
CategoryClinical service
Description

Diagnosis and treatment of sleep disorders including snoring, sleep apnea, insomnia, and narcolepsy, with hypoglossal nerve stimulation treatment available for obstructive sleep apnea.

17Thyroid and Parathyroid Endocrine Surgery
CategoryClinical service
Description

High-volume surgical treatment of thyroid and parathyroid disorders using intraoperative nerve monitoring in over 3,500 cases, with radiofrequency ablation clinic for non-surgical tumor reduction.

18Voice, Swallowing, and Breathing Centers
Description

Laryngology services for voice box and upper airway disorders, plus Voice and Speech Laboratory for evaluation and rehabilitation of voice and throat conditions.

Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2011-01-01
Description

Merger in 2011 created the world's largest vision and hearing research center. The institute became a subsidiary of the Mass. Eye and Ear Foundation, combining Mass Eye and Ear's clinical expertise with Schepens' basic science research capabilities.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Mass Eye and Ear is a teaching hospital of Harvard Medical School and serves as the flagship research and teaching hospital of the Harvard Medical School Department of Ophthalmology.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Mass Eye and Ear is a member of Mass General Brigham healthcare system, providing integrated care across academic medical centers and specialty hospitals.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

International clinical trial collaboration for OTOF gene therapy for inherited deafness. Researchers from Mass Eye and Ear and Fudan University jointly published findings in Nature (April 2026) demonstrating 90% response rate in 42 participants.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Adjacent campus providing reciprocal medical and surgical support. Mass Eye and Ear clinicians staff MGH Department of Ophthalmology. Shared emergency department coordination and tertiary referrals.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Mass Eye and Ear ophthalmologists provide comprehensive and subspecialty care, including 24/7 emergency eye care and trauma coverage at these affiliated hospitals.

7Children's Hospital Ophthalmology Foundation
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration providing world-class pediatric eye care for children with the full range of eye conditions. Mass Eye and Ear clinicians staff comprehensive pediatric ophthalmology and adult strabismus service.

masseyeandear.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

International academic partnership for eye care research and training collaboration.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

International academic partnership for eye care research and training collaboration.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Stein Eye Institute (UCLA)
TypeDirect peer
Description

UCLA's ophthalmology specialty center with strong research and clinical programs; directly comparable as a leading academic ophthalmology institution on the West Coast.

TypeDirect peer
Description

Johns Hopkins' ophthalmology specialty center, combining research, education, and patient care; directly comparable to Mass Eye and Ear as an academic ophthalmology leader.

TypeDirect peer
Description

A specialty hospital in Philadelphia dedicated exclusively to ophthalmology; among the oldest and most prominent eye hospitals in the U.S., directly comparable to Mass Eye and Ear as a leading academic specialty eye institution.

TypeDirect peer
Description

Specialty hospital focused on eye and ENT care, now part of the Mount Sinai Health System; the closest direct peer given the eye and ear specialty focus and academic medical center affiliation.

TypeDirect peer
Description

University of Miami Health System's ophthalmology specialty hospital, consistently ranked among the top eye institutions in the U.S.; directly comparable as a research-driven ophthalmology specialty provider.

6Byers Eye Institute (Stanford)
TypeDirect peer
Description

Stanford's ophthalmology specialty center with cutting-edge research; directly comparable as a leading academic ophthalmology institution with translational research focus.

TypeBroad incumbent
Description

Cleveland Clinic's ophthalmology center, part of a broader multispecialty academic medical system; comparable to Mass Eye and Ear as a research-active ophthalmology provider within a larger integrated delivery network.

TypeBroad incumbent
Description

Mayo Clinic's ophthalmology department, embedded in a broader multispecialty academic medical center; comparable as a top-tier research and clinical ophthalmology program within a diversified system.

TypeDirect peer
Description

Los Angeles-based specialty practice focused on otology and neurotology (ear and hearing disorders); directly comparable as a leading specialty ENT provider with research and clinical focus.

TypeDirect peer
Description

University of Michigan's ophthalmology and visual sciences center; directly comparable as a leading academic ophthalmology institution with strong research and clinical programs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles22 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Massachusetts Eye and Ear Infirmly

Specialty Hospital Services - Ophthalmology and Otolaryngologymasseyeandear.org

Massachusetts Eye and Ear Infirmary is a Harvard Medical School teaching hospital and Mass General Brigham member delivering specialty clinical care and research across ophthalmology and otolaryngology, serving patients through 20+ locations in greater Boston and Providence and a 24/7 dedicated emergency department.

What Massachusetts Eye and Ear Infirmly does

Massachusetts Eye and Ear Infirmary (Mass Eye and Ear) is a private, nonprofit academic medical center founded in 1824 and headquartered at 243 Charles Street, Boston. It is the primary teaching hospital of Harvard Medical School's Departments of Ophthalmology and Otolaryngology and a member of the Mass General Brigham health system. The institution delivers specialty clinical care exclusively across eye, ear, nose, throat, head, and neck conditions — including cornea, retina, glaucoma, neuro-ophthalmology, pediatric ophthalmology, audiology, head and neck cancer surgery, facial plastics, sinus, sleep medicine, thyroid/parathyroid, and voice/swallowing services — supported by a 24/7 dedicated emergency department that treats over 20,000 patients per year and is the only such facility in New England.

The organization operates through more than 20 physical locations across greater Boston and Providence, plus virtual visits and a dedicated International Patient Center. Underlying clinical capabilities rest on a research-to-care pipeline anchored by the Schepens Eye Research Institute (subsidiary since 2011), which together make Mass Eye and Ear the world's largest vision and hearing research center. The institution has pioneered several foundational ophthalmic technologies — Optical Coherence Tomography (OCT), anti-VEGF therapy for wet AMD (Macugen and foundational science behind Lucentis), photodynamic therapy, and proton beam therapy for eye tumors — and is currently advancing OTOF gene therapy for inherited deafness (90% response rate, 2.5+ year durability in trial) and CALEC limbal stem cell transplantation for limbal stem cell deficiency (93% manufacturing success).

Revenue is generated through clinical care billed to insurance, Medicare/Medicaid, and self-pay patients (including a self-pay laser vision correction promotion at $500 per procedure or $250 per eye), supplemented by industry- and government-funded clinical research. The go-to-market is direct-to-consumer with patients acquired via physician referrals, scheduled appointments, walk-in emergency visits, and an international patient office. Notable commercial signals include a $1M Yawkey Foundation grant for ED renovation (September 2025), training of more than 80 current chiefs at peer institutions, and ongoing international collaborations with Fudan University (China), Aravind Eye Hospital (India), and LV Prasad Eye Institute (India).

Massachusetts Eye and Ear Infirmly firmographics

Firmographics
Name
Massachusetts Eye and Ear Infirmly
Legal name
Massachusetts Eye and Ear
Website
https://masseyeandear.org
Company type
Private
Founded year
1824
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Massachusetts Eye and Ear Infirmary is a Harvard Medical School teaching hospital and Mass General Brigham member delivering specialty clinical care and research across ophthalmology and otolaryngology, serving patients through 20+ locations in greater Boston and Providence and a 24/7 dedicated emergency department.
Ownership category
akta.pro rank

Massachusetts Eye and Ear Infirmly industry classification

Industry
Product category
Specialty Hospital Services - Ophthalmology and Otolaryngology
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Offices of Optometrists (62132), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Offices of Physicians (62111)
SIC
Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro primary industry
Ophthalmic Specialty Hospitals (HLAFAHAJ)

Keywords

  • Specialty hospital services
  • Ophthalmology care
  • Otolaryngology care
  • Vision research
  • Hearing research

Where Massachusetts Eye and Ear Infirmly is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Offices22 records

Markets served

Massachusetts Eye and Ear Infirmly business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Patient Care Services: Clinical services including emergency department (24/7), outpatient visits, diagnostic tests, and surgical procedures across ophthalmology and otolaryngology specialties. Revenue generated through insurance reimbursements, government programs (Medicare/Medicaid), and patient payments.
  2. Specialty Surgical Procedures: Advanced surgical interventions including cataract surgery, LASIK, cochlear implants, head and neck cancer surgery, thyroid/parathyroid surgery. Billed per procedure with facility fees.
  3. Clinical Research: Government and industry-funded clinical trials generating research revenue while providing cutting-edge treatments to patients.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goStandard specialty care consultation and treatment
Unit PricingPay-as-you-goLaser vision correction surgery promotional pricing

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Massachusetts Eye and Ear Infirmly product offering

Product offering

Core offering

Massachusetts Eye and Ear is a specialty academic medical center providing clinical care, research, and training in ophthalmology and otolaryngology. It operates a comprehensive portfolio of subspecialty clinical services spanning eye care (cornea, retina, glaucoma, cataract, neuro-ophthalmology, pediatric ophthalmology, refractive surgery, ophthalmic plastic surgery) and ear, nose, throat, head and neck care (audiology, head and neck cancer, facial plastics, sinus, sleep medicine, thyroid/parathyroid surgery, voice and swallowing). The institution runs New England's only 24/7 dedicated eye and ENT emergency department, conducts clinical trials including gene therapies for inherited deafness and blindness, and serves as the primary teaching hospital of Harvard Medical School's Departments of Ophthalmology and Otolaryngology.

Product overview

Mass Eye and Ear is a specialized academic medical center offering a comprehensive portfolio of clinical services across ophthalmology (eye care) and otolaryngology (ear, nose, throat, head and neck care), with supporting clinical and support services. The institution operates as a single integrated healthcare delivery system rather than a platform-plus-modules architecture, organized into distinct clinical subspecialties including Cornea, Retina, Glaucoma, Neuro-Ophthalmology, Audiology, Head and Neck Cancer Surgery, Facial Plastics, Sinus Center, Sleep Medicine, Thyroid/Parathyroid Surgery, and Voice/Swallowing services, among others. Supporting infrastructure includes emergency care (New England's only 24/7 dedicated ENT/eye emergency department), hyperbaric medicine, radiology, interpreter services, and a patient portal (Mass General Brigham Patient Gateway). The institution also conducts clinical trials for experimental treatments including gene therapies for inherited deafness and CRISPR-based treatments for inherited blindness.

Differentiator

Problem solved

Functional benefit

Products and services

  • Optometry and Contact Lens Service Comprehensive eye examinations, eyeglass prescriptions, and contact lens fitting services including specialty lenses for keratoconus, astigmatism, bifocal, prosthetic, and post-surgical applications. For patients requiring corrective lenses and specialty contact lens fitting.
  • Retina Service Diagnosis and treatment of retinal diseases including age-related macular degeneration (AMD), diabetic retinopathy, retinal detachment, and inherited retinal disorders using advanced tools and clinical trials. For patients with retinal conditions.
  • Cornea Service Treatment of corneal diseases including stem cell transplantation, ocular surface reconstruction, lamellar keratoplasty, artificial cornea transplants, and Corneal Tissue Addition Keratoplasty (CTAK). For patients with common, complex, and high-risk corneal and external diseases.
  • Glaucoma Service Full-spectrum glaucoma care including medical therapy, traditional surgery, and minimally invasive glaucoma surgeries (MIGS) for patients of all ages with all forms and stages of the disease.
  • Neuro-Ophthalmology Service Treatment of complex central nervous system disorders affecting vision including optic neuritis, ischemic optic neuropathy, brain tumors, strokes, myasthenia gravis, and diplopia. Sees just under 6,000 patients each year.
  • Laser Vision Correction/Refractive Surgery Laser eye surgery including LASIK, SMILE, PRK, EVO ICL implantable lenses, and refractive lens exchange for correction of nearsightedness, farsightedness, astigmatism, and presbyopia.
  • Comprehensive Ophthalmology and Cataract Consultation Routine eye exams, cataract surgery, and management of common eye problems performed by comprehensive ophthalmologists at multiple Boston-area locations.
  • Pediatric Ophthalmology Eye care for children including routine vision screenings and treatment of conditions such as retinopathy of prematurity, childhood cataract, glaucoma, strabismus, and amblyopia, in collaboration with Children's Hospital.
  • Ophthalmic Plastic Surgery Surgical treatment of functional disorders of eyelids, eye socket, and tear drainage system, plus cosmetic procedures including eyelid surgery, BOTOX, and injectable treatments.
  • Ocular Immunology and Uveitis Service Diagnosis and treatment of inflammatory eye diseases (uveitis) and immunological disorders, working across retina, cornea, immunology, and uveitis specialties.
  • Audiology and Hearing Services Hearing assessment, hearing aids, cochlear implants, bone conduction devices, auditory brainstem implants, and pediatric hearing services across 11 locations in Eastern Massachusetts.
  • General Ear, Nose, and Throat Care Initial assessment and treatment for wide variety of ENT disorders in adults and children including infections, throat/swallowing disorders, voice problems, nasal/sinus disorders, and thyroid conditions. Provided by 70+ physicians across 15 locations.
  • Facial Plastic and Reconstructive Surgery Reconstructive and cosmetic procedures including rhinoplasty, facial nerve disorders, skin cancer treatment, laser procedures, and microtia/ear reconstruction at five New England locations.
  • Head and Neck Cancer Surgery Diagnosis, treatment, reconstruction, and rehabilitation of head and neck cancers using advanced surgical techniques including microvascular surgery, robotic surgery, and skull-base surgery.
  • Rasmussen Family Sinus Center Evaluation and treatment of sinus problems including chronic sinusitis, nasal congestion, smell/taste disorders, nasal polyps, tumors, and CSF leaks using latest medical and surgical techniques.
  • Sleep Medicine and Surgery Diagnosis and treatment of sleep disorders including snoring, sleep apnea, insomnia, and narcolepsy, with hypoglossal nerve stimulation treatment available for obstructive sleep apnea.
  • Thyroid and Parathyroid Endocrine Surgery High-volume surgical treatment of thyroid and parathyroid disorders using intraoperative nerve monitoring in over 3,500 cases, with radiofrequency ablation clinic for non-surgical tumor reduction.
  • Voice, Swallowing, and Breathing Centers Laryngology services for voice box and upper airway disorders, plus Voice and Speech Laboratory for evaluation and rehabilitation of voice and throat conditions.

Quantifiable outcome

  • 90% of 42 participants showed hearing improvement from OTOF gene therapy with results lasting 2.5+ years
  • +3 more outcomes

Companies that use Massachusetts Eye and Ear Infirmly

Customer profile

Named customers2 records

Segments5 records

Ideal customer profiles4 records

Massachusetts Eye and Ear Infirmly technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Massachusetts Eye and Ear Infirmly partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered flagship, core and minor.

  • Schepens Eye Research Institute of Mass. Eye and EarflagshipStrategic or Co-development Partner · 1 January 2011Merger in 2011 created the world's largest vision and hearing research center. The institute became a subsidiary of the Mass. Eye and Ear Foundation, combining Mass Eye and Ear's clinical expertise with Schepens' basic science research capabilities.
  • Harvard Medical SchoolflagshipStrategic or Co-development PartnerMass Eye and Ear is a teaching hospital of Harvard Medical School and serves as the flagship research and teaching hospital of the Harvard Medical School Department of Ophthalmology.
  • Mass General BrighamflagshipStrategic or Co-development PartnerMass Eye and Ear is a member of Mass General Brigham healthcare system, providing integrated care across academic medical centers and specialty hospitals.
  • Fudan University (Shanghai Eye and ENT Hospital)coreStrategic or Co-development PartnerInternational clinical trial collaboration for OTOF gene therapy for inherited deafness. Researchers from Mass Eye and Ear and Fudan University jointly published findings in Nature (April 2026) demonstrating 90% response rate in 42 participants.
  • Massachusetts General HospitalflagshipStrategic or Co-development PartnerAdjacent campus providing reciprocal medical and surgical support. Mass Eye and Ear clinicians staff MGH Department of Ophthalmology. Shared emergency department coordination and tertiary referrals.
  • Brigham and Women's Hospital and Brigham and Women's Faulkner HospitalcoreStrategic or Co-development PartnerMass Eye and Ear ophthalmologists provide comprehensive and subspecialty care, including 24/7 emergency eye care and trauma coverage at these affiliated hospitals.
  • Children's Hospital Ophthalmology FoundationcoreStrategic or Co-development PartnerCollaboration providing world-class pediatric eye care for children with the full range of eye conditions. Mass Eye and Ear clinicians staff comprehensive pediatric ophthalmology and adult strabismus service.
  • Aravind Eye Hospital (Madurai, India)minorStrategic or Co-development PartnerInternational academic partnership for eye care research and training collaboration.
  • LV Prasad Eye Institute (Hyderabad, India)minorStrategic or Co-development PartnerInternational academic partnership for eye care research and training collaboration.

Scale indicators14 records

Recent moves5 records

Expansion highlights5 records

Massachusetts Eye and Ear Infirmly competitors and assessment

Company assessment

Direct peers

  • Stein Eye Institute (UCLA): UCLA's ophthalmology specialty center with strong research and clinical programs; directly comparable as a leading academic ophthalmology institution on the West Coast.
  • Wilmer Eye Institute (Johns Hopkins): Johns Hopkins' ophthalmology specialty center, combining research, education, and patient care; directly comparable to Mass Eye and Ear as an academic ophthalmology leader.
  • Wills Eye Hospital: A specialty hospital in Philadelphia dedicated exclusively to ophthalmology; among the oldest and most prominent eye hospitals in the U.S., directly comparable to Mass Eye and Ear as a leading academic specialty eye institution.
  • New York Eye and Ear Infirmary of Mount Sinai: Specialty hospital focused on eye and ENT care, now part of the Mount Sinai Health System; the closest direct peer given the eye and ear specialty focus and academic medical center affiliation.
  • Bascom Palmer Eye Institute: University of Miami Health System's ophthalmology specialty hospital, consistently ranked among the top eye institutions in the U.S.; directly comparable as a research-driven ophthalmology specialty provider.
  • Byers Eye Institute (Stanford): Stanford's ophthalmology specialty center with cutting-edge research; directly comparable as a leading academic ophthalmology institution with translational research focus.
  • House Clinic: Los Angeles-based specialty practice focused on otology and neurotology (ear and hearing disorders); directly comparable as a leading specialty ENT provider with research and clinical focus.
  • Michigan Medicine Kellogg Eye Center: University of Michigan's ophthalmology and visual sciences center; directly comparable as a leading academic ophthalmology institution with strong research and clinical programs.

Broad incumbents

  • Cleveland Clinic Cole Eye Institute: Cleveland Clinic's ophthalmology center, part of a broader multispecialty academic medical system; comparable to Mass Eye and Ear as a research-active ophthalmology provider within a larger integrated delivery network.
  • Mayo Clinic Department of Ophthalmology: Mayo Clinic's ophthalmology department, embedded in a broader multispecialty academic medical center; comparable as a top-tier research and clinical ophthalmology program within a diversified system.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Massachusetts Eye and Ear Infirmly social profiles

Digital presence

Massachusetts Eye and Ear Infirmly financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Massachusetts Eye and Ear Infirmly leadership team

Management profile

Number of profiles

Profiles22 records

Massachusetts Eye and Ear Infirmly subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Massachusetts Eye and Ear Infirmly funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Massachusetts Eye and Ear Infirmly M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Massachusetts Eye and Ear Infirmly

What does Massachusetts Eye and Ear Infirmly do?

Massachusetts Eye and Ear is a specialty academic medical center providing clinical care, research, and training in ophthalmology and otolaryngology. It operates a comprehensive portfolio of subspecialty clinical services spanning eye care (cornea, retina, glaucoma, cataract, neuro-ophthalmology, pediatric ophthalmology, refractive surgery, ophthalmic plastic surgery) and ear, nose, throat, head and neck care (audiology, head and neck cancer, facial plastics, sinus, sleep medicine, thyroid/parathyroid surgery, voice and swallowing). The institution runs New England's only 24/7 dedicated eye and ENT emergency department, conducts clinical trials including gene therapies for inherited deafness and blindness, and serves as the primary teaching hospital of Harvard Medical School's Departments of Ophthalmology and Otolaryngology.

Is Massachusetts Eye and Ear Infirmly a public or private company?

Massachusetts Eye and Ear Infirmly is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Massachusetts Eye and Ear Infirmly founded?

Massachusetts Eye and Ear Infirmly was founded in 1824. It employs 1,001 to 5,000 people.

Where is Massachusetts Eye and Ear Infirmly based?

Massachusetts Eye and Ear Infirmly is headquartered in Boston, United States, in the North America region.

How does Massachusetts Eye and Ear Infirmly make money?

Three revenue lines are on record. Patient Care Services are the primary driver. The others are specialty Surgical Procedures and clinical Research.

Who are Massachusetts Eye and Ear Infirmly's main competitors?

Direct peers on record are Stein Eye Institute (UCLA), Wilmer Eye Institute (Johns Hopkins), Wills Eye Hospital, New York Eye and Ear Infirmary of Mount Sinai, Bascom Palmer Eye Institute, Byers Eye Institute (Stanford), House Clinic and Michigan Medicine Kellogg Eye Center. Broad incumbents are Cleveland Clinic Cole Eye Institute and Mayo Clinic Department of Ophthalmology.

Does Massachusetts Eye and Ear Infirmly have an API?

No public API is recorded for Massachusetts Eye and Ear Infirmly.

What industry is Massachusetts Eye and Ear Infirmly in?

Massachusetts Eye and Ear Infirmly's product category is Specialty Hospital Services - Ophthalmology and Otolaryngology. Its primary akta.pro industry code is HLAFAHAJ, Ophthalmic Specialty Hospitals. Its NAICS code is 62231 and its SIC code is 8062.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Ophthalmology Times'Father of modern corneal science’ Claes H. Dohlman, MD, PhD, passes away at 101Claes H. Dohlman, MD, PhD, a pioneering ophthalmologist known as the father of modern corneal science, passed away on July 14, 2024, at the age of 101. During his career at Mass Eye and Ear and Harvard Medical School, he established the world's first cornea subspecialty clinic and pioneered the Boston Keratoprosthesis, an artificial cornea implant that has seen 19,000 procedures to date. His legacy includes training over 200 specialists and receiving prestigious honors such as the 2022 António Champalimaud Vision Award.LegacyARNOLD KROLL Obituary (2026)Arnold J. Kroll, a renowned retinal surgeon and Clinical Professor of Ophthalmology at Tufts University School of Medicine, passed away on January 27, 2026, at the age of 91. He had a distinguished medical career involving research and surgery at institutions such as Massachusetts Eye and Ear Infirmary and Bascom Palmer Eye Institute. His funeral services are scheduled for late January 2026 in Massachusetts.Harvard GazetteHarvard’s eardrum-restoring PhonoGraft enters commercial developmentDesktop Health has acquired Beacon Bio to commercialize PhonoGraft, a 3D-printed biomimetic eardrum graft developed by researchers at Harvard’s Wyss Institute and Massachusetts Eye and Ear. The acquisition transfers the exclusive license for the technology from Harvard, enabling Desktop Health to pursue FDA clearance and bring the regenerative medicine solution to patients.PR NewswireQuickSee handheld autorefractor can dramatically increase access to eyeglasses, study findsA study published by researchers at the Aravind Eye Institute in India, Johns Hopkins University, and Massachusetts Eye and Ear Institute found that eyeglasses made from PlenOptika's QuickSee handheld autorefractor measurements were accepted equally by patients compared to those made from traditional subjective refraction. The research suggests QuickSee's accuracy and portability could radically expand access to eyeglasses in remote and low-resource settings, where uncorrected refractive error affects over 1 billion people worldwide and causes at least $410 billion in annual productivity loss. PlenOptika, which has used QuickSee to measure over 3 million people in 45 countries, hopes this independent validation gives vision care professionals and NGOs confidence to adopt the technology.PR NewswireSanten Announces Global Research Initiative with Massachusetts Eye and Ear and Ulster University Researchers to Study and Develop New Treatments for GlaucomaSanten, a global pharmaceutical company specializing in ophthalmology, announced a research initiative with scientists from Massachusetts Eye and Ear and Ulster University to develop novel treatments for glaucoma, a leading cause of blindness affecting an estimated 79.6 million people worldwide. The collaboration will focus on targeting the NLRP3 inflammasome using a novel biologic called InflaMab, with the goal of stopping the degeneration of optic nerve cells and preserving vision in glaucoma patients. The research represents a multi-institutional effort combining industry expertise with academic research capabilities to address an unmet medical need, as there are currently no effective treatments that protect the optic nerve from degeneration.PR NewswireReNeuron Announces Retinal Clinical Trial Progresses to Next StageReNeuron Group plc announced that its Phase I/II clinical trial for the hRPC cell therapy candidate treating retinitis pigmentosa has progressed to the second dosing cohort at Massachusetts Eye and Ear in Boston, following a positive Data Safety Monitoring Board review. The first cohort of three patients had reported significant vision improvement equivalent to reading three additional lines on the EDTRS eye chart. The company expects to report further short-term results from the study in mid-2019, with the therapy benefiting from Orphan Drug Designation in both Europe and the US, as well as Fast Track designation from the FDA.PR NewswireOcugen Expands Focus on Inherited Retinal Disorders by Licensing Novel Modifier Gene Therapy PlatformOcugen announced an exclusive worldwide license to develop and commercialize a novel modifier gene therapy platform from the Schepens Eye Research Institute of Massachusetts Eye and Ear. This strategic expansion aims to address inherited retinal disorders by targeting nuclear hormone receptors to potentially halt disease progression across genetically diverse conditions. The partnership leverages technology developed by Dr. Neena Haider to offer broader therapeutic options than single-gene replacement therapies.PR NewswireAntibiotic gel squirted into the ear could provide a one-dose cure for ear infectionsResearchers at Boston Children's Hospital, in collaboration with Boston Medical Center and Massachusetts Eye and Ear, have developed a bioengineered gel that, when squirted into the ear canal, can deliver a full course of antibiotic therapy for middle ear infections in a single dose, using FDA-approved chemical permeation enhancers to penetrate the eardrum. In preclinical testing on chinchillas, the gel completely cured ear infections in 10 of 10 animals compared to ordinary ciprofloxacin ear drops which cleared infections in only 5 of 8 animals, while avoiding systemic antibiotic exposure and potential side effects. The research team, led by Daniel Kohane, has received NIH funding and plans to form a company to begin clinical testing in patients.Harvard GazetteBicarbonate for Better Vision?Researchers from Harvard Medical School and Massachusetts Eye and Ear discovered that bicarbonate modifies visual signals by stimulating guanylate cyclase to synthesize cGMP in rod and cone photoreceptors. This mechanism improves the ability to track moving objects, leading scientists to investigate whether controlling bicarbonate levels could slow or prevent retinal diseases characterized by lethal cGMP accumulation.GlobeNewswireNeoStem and Mass. Eye and Ear/Schepens Eye Research Institute Announce Second Research Collaboration Exploring NeoStem's VSEL(TM) Technology for Retinal RepairNeoStem announced a sponsored research collaboration with Mass. Eye and Ear/Schepens Eye Research Institute to study VSELs and CD34+ cells for retinal repair. The research will use animal models to assess cell migration, integration, and differentiation into retinal cells. The collaboration aims to explore potential treatments for macular degeneration and retinitis pigmentosa.